Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BIOAF

Bioasis Technologies (CE) (BIOAF)

Bioasis Technologies Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:BIOAF
DateTimeSourceHeadlineSymbolCompany
06/20/20147:30PMMarketwiredbiOasis Appoints New Chief Financial Officer and Corporate SecretaryUSOTC:BIOAFBioasis Technologies Inc (CE)
06/16/20149:00AMMarketwiredbiOasis Enters Investor Relations Agreement with Gale Capital CorporationUSOTC:BIOAFBioasis Technologies Inc (CE)
05/08/20149:00AMMarketwiredbiOasis Secures DTC EligibilityUSOTC:BIOAFBioasis Technologies Inc (CE)
05/06/20149:00AMMarketwiredbiOasis Delivers siRNA to the Brain Using its Transcend Peptide VectorUSOTC:BIOAFBioasis Technologies Inc (CE)
04/24/20149:00AMMarketwiredbiOasis Discovers the Keys to Transcend to Advance Its Program for the Delivery of Therapeutics Across the Blood-Brain BarrierUSOTC:BIOAFBioasis Technologies Inc (CE)
04/03/20149:00AMMarketwiredbiOasis Presents Results From It's BT2111 Program at International Cancer Research ConferenceUSOTC:BIOAFBioasis Technologies Inc (CE)
03/27/20149:00AMMarketwiredbiOasis Receives Patent Allowances for Lysosomal Storage Disease Therapeutic in Europe and CanadaUSOTC:BIOAFBioasis Technologies Inc (CE)
03/17/20149:00AMMarketwiredbiOasis Enters Into a License Agreement With Medimmune for Second Generation Versions of biOasis's TranscendUSOTC:BIOAFBioasis Technologies Inc (CE)
03/06/201412:00AMOTC MarketsPiggyback QualifiedUSOTC:BIOAFBioasis Technologies Inc (CE)
02/24/20149:00AMMarketwiredbiOasis to Begin Trading on OTCQX® Marketplace in the U.S.USOTC:BIOAFBioasis Technologies Inc (CE)
 Showing the most relevant articles for your search:USOTC:BIOAF